News coverage about Medical Transcription Billing, Corp. (NASDAQ:MTBC) has been trending somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Medical Transcription Billing, Corp. earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 46.3849787049612 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the media headlines that may have effected Accern Sentiment’s rankings:

Shares of Medical Transcription Billing, Corp. (MTBC) opened at 2.78 on Friday. Medical Transcription Billing, Corp. has a one year low of $0.29 and a one year high of $5.44. The company’s market capitalization is $31.83 million. The stock has a 50 day moving average price of $1.61 and a 200 day moving average price of $1.43.

Medical Transcription Billing, Corp. (NASDAQ:MTBC) last issued its quarterly earnings results on Thursday, August 3rd. The technology company reported ($0.02) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.17) by $0.15. The firm had revenue of $7.79 million for the quarter. Medical Transcription Billing, Corp. had a negative net margin of 32.88% and a negative return on equity of 59.52%. On average, equities research analysts predict that Medical Transcription Billing, Corp. will post ($0.69) earnings per share for the current year.

A number of equities research analysts have commented on MTBC shares. Zacks Investment Research raised Medical Transcription Billing, Corp. from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a report on Wednesday, August 16th. ValuEngine raised Medical Transcription Billing, Corp. from a “sell” rating to a “hold” rating in a report on Wednesday, August 2nd.

WARNING: “Medical Transcription Billing, Corp. (MTBC) Receives Daily News Sentiment Rating of 0.19” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/10/08/medical-transcription-billing-corp-mtbc-receives-daily-news-sentiment-rating-of-0-19.html.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Insider Buying and Selling by Quarter for Medical Transcription Billing, Corp. (NASDAQ:MTBC)

Receive News & Stock Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related stocks with our FREE daily email newsletter.